Evidence map›Paper›PMID 12485116›Full record

ReviewThe Biochemical journal2003

Positive and negative regulation of T-cell activation through kinases and phosphatases.

Tomas Mustelin, Kjetil Taskén

Open access · bronzeAbstract readReview
In one paragraph

Review in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 267 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Discovery of Pyridazinone and Pyrazolo[1,5-ACS medicinal chemistry letters · 2019
    Article
  17. The Contribution of PTPN22 to Rheumatic Disease.Arthritis & rheumatology (Hoboken, N.J.) · 2019
    Review
  18. Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Tomas MustelinProgram of Signal Transduction, Cancer Center, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Kjetil Taskén
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sequence of events in T-cell antigen receptor (TCR) signalling leading to T-cell activation involves regulation of a number of protein tyrosine kinases (PTKs) and the phosphorylation status of many of their substrates. Proximal signalling pathways involve PTKs of the Src, Syk, Csk and Tec families, adapter proteins and effector enzymes in a highly organized tyrosine-phosphorylation cascade. In intact cells, tyrosine phosphorylation is rapidly reversible and generally of a very low stoichiometry even under induced conditions due to the fact that the enzymes removing phosphate from tyrosine-phosphorylated substrates, the protein tyrosine phosphatases (PTPases), have a capacity that is several orders of magnitude higher than that of the PTKs. It follows that a relatively minor change in the PTK/PTPase balance can have a major impact on net tyrosine phosphorylation and thereby on activation and proliferation of T-cells. This review focuses on the involvement of PTKs and PTPases in positive and negative regulation of T-cell activation, the emerging theme of reciprocal regulation of each type of enzyme by the other, as well as regulation of phosphotyrosine turnover by Ser/Thr phosphorylation and regulation of localization of signal components.

Indexed as

AnimalsCSK Tyrosine-Protein KinaseHumansIsoenzymesLeukocyte Common AntigensLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)Phosphoric Monoester HydrolasesPhosphotransferasesProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 12Protein Tyrosine PhosphatasesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynReceptors, Antigen, T-CellSignal TransductionACP1 protein, humanCSK protein, humanCSK Tyrosine-Protein KinaseFYN protein, humanIsoenzymesLeukocyte Common AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)Phosphoric Monoester HydrolasesPhosphotransferasesProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 12Protein Tyrosine PhosphatasesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynPTPN12 protein, humanReceptors, Antigen, T-Cellsrc-Family KinasesZAP70 protein, humanZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID12485116
PMCPMC1223257
OpenAlexW1997546191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.